Replies to post #510 on Clinuvel Pharmaceuticals (CLVLY)

[ghmm]

I went back over a few 4C's to see if (past) production estimates had any future correlation with actual production costs or revenue and couldn't find any. My guess is they are guessing :-)

Some of the other expense estimates did seem to be more inline. So to me the most notable (and IMO good sign) is the staffing costs are rising substantially! About A$600 which annualized is $2.4M so my guess is they are close to doubling staff. Thinking more about it its even more as they won't hire all on day 1 and could be more hired in future quarters.